Journal of Nanomedicine & Biotherapeutic Discovery
Open Access

Physicochemical Properties of Nanoliposomes by Nanocarriers and Drugs

Seyedeh Hoda^{* *}Correspondence: Seyedeh Hoda, Department of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran, Email:

Author info »

Description

Nanoliposomes are a class of nanoscale drug delivery systems that have gained significant attention in the field of medicine and pharmaceuticals [1-3]. Comprising a lipid bilayer structure, these tiny spheres, often just tens of nanometers in diameter, encapsulate therapeutic agents with precision [3-5]. Nanoliposomes consist of a lipid bilayer, primarily composed of phospholipids, which mimics the structure of natural cell membranes. Within this lipid bilayer, therapeutic agents can be encapsulated, whether they are hydrophobic compounds nestled in the lipid core or hydrophilic molecules sequestered in the aqueous core [6-8].

The anatomy of nanoliposomes

Biocompatibility: Lipids are naturally occurring molecules in the body, rendering nanoliposomes biocompatible and less likely to provoke an immune response.

Customized drug delivery: The composition and size of nanoliposomes can be fine-tuned to control the release kinetics of the encapsulated drugs. This allows for precise drug delivery and enhanced therapeutic efficacy [9].

Protection of cargo: The lipid bilayer serves as a protective shield, safeguarding the encapsulated drugs from degradation or premature release until they reach their intended target.

Applications of nanoliposomes as nanocarriers

The versatility of nanoliposomes as drug delivery systems has led to a wide array of applications in the fields of medicine and pharmaceuticals:

Cancer therapy: Nanoliposomes are extensively utilized in cancer therapy for the targeted delivery of chemotherapeutic drugs. Surface modifications with targeting ligands ensure the liposomes home in on cancer cells, reducing damage to healthy tissues and minimizing side effects [10].

Infectious disease treatments: Nanoliposomes are good carriers for antimicrobial medicines such as antibiotics and antiviral medications in the fight against infectious illnesses. Their small size allows them to penetrate bacterial or viral membranes, enhancing drug efficacy.

Gene therapy: Nanoliposomes can deliver genetic material, such as DNA or RNA, to target cells. This approach holds immense potential for gene therapy, where defective genes can be replaced or modified to treat genetic disorders.

Enhanced oral drug delivery: Nanoliposomes can protect drugs from the discomfort gastrointestinal environment, facilitating the oral delivery of compounds that are otherwise poorly absorbed.

Future directions and challenges

Despite their incredible potential, the field of nanoliposomes faces some challenges and areas for future exploration:

Biocompatibility and safety: While nanoliposomes are generally biocompatible, further research is needed to ensure their longterm safety and potential side effects [11].

Regulatory approval: The regulatory landscape for nanoliposomes is evolving. Ensuring that these innovative drug delivery systems meet stringent safety and efficacy standards is essential.

Cost-effectiveness: Developing cost-effective manufacturing processes for nanoliposomes is vital to ensure their accessibility and affordability for a broad range of patients.

Targeting specific diseases: Customized nanoliposomes for specific diseases and optimizing their targeting capabilities represent an ongoing challenge and opportunity for research.

Conclusion

Nanoliposomes, as nanocarriers, are playing a pivotal role in revolutionizing drug delivery. Their ability to encapsulate and deliver therapeutic agents with precision, protect them from degradation, and target specific tissues or cells is reshaping the landscape of medicine and pharmaceuticals. As research in this field continues to expand, we can anticipate even more innovative applications of nanoliposomes, further enhancing our ability to combat diseases and improve patient outcomes.

References

1. Demirci M, Caglar MY, Cakir B, Gülseren İ. Encapsulation by nanoliposomes. Nanoencapsulation technologies for the food and nutraceutical industries. 2017;22:74-113.

   [Crossref] [Google Scholar]

2. Ding B, Zhang X, Hayat K, Xia S, Jia C, Xie M, et al. Preparation, characterization and the stability of ferrous glycinate nanoliposomes. J. Food Eng. 2011;102(2):202-208.

   [Crossref] [Google Scholar]

3. Su C, Liu Y, He Y, Gu J. Analytical methods for investigating in vivo fate of nanoliposomes: A review. J. Pharm. Anal. 2018;8:219-225.

   [Crossref] [Google Scholar] [PubMed]

4. Colas JC, Shi W, Rao VM, Omri A, Mozafari MR, Singh H. Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron. 2007;38(8):841-847.

   [Crossref] [Google Scholar] [PubMed]

5. Bondu C, Yen FT. Nanoliposomes, from food industry to nutraceuticals: Interests and uses. Innov Food Sci Emerg Technol. 2022;11:103-140.

   [Crossref] [Google Scholar]

6. Bilal M, Qindeel M, Raza A, Mehmood S, Rahdar A. Stimuli-responsive nanoliposomes as prospective nanocarriers for targeted drug delivery. J. Drug Deliv. 2021;66:102-116.

   [Crossref] [Google Scholar]

7. Pezeshky A, Ghanbarzadeh B, Hamishehkar H, Moghadam M, Babazadeh A. Vitamin A palmitate-bearing nanoliposomes: Preparation and characterization. Food Biosci. 2016;13:49-55.

   [Crossref] [Google Scholar]

8. Mohammadi R, Mahmoudzadeh M, Atefi M, Khosravi‐Darani K, Mozafari MR. Applications of nanoliposomes in cheese technology. Int. J. Dairy Technol. 2015;68(1):11-23.

   [Crossref] [Google Scholar]

9. Bouarab L, Maherani B, Kheirolomoom A, Hasan M, Aliakbarian B, Linder M, et al. Influence of lecithin–lipid composition on physico-chemical properties of nanoliposomes loaded with a hydrophobic molecule. Colloids Surf. B. 2014;115:197-204.

   [Crossref] [Google Scholar] [PubMed]

10. Liu W, Liu WL, Liu CM, Liu JH, Yang SB, Zheng HJ, et al. Medium-chain fatty acid nanoliposomes for easy energy supply. Nutr. J. 2011;27(6):700-706.

    [Crossref] [Google Scholar] [PubMed]

11. Hamadou AH, Huang WC, Xue C, Mao X. Comparison of β-carotene loaded marine and egg phospholipids nanoliposomes. J. Food Eng. 2020;283:110-115.

    [Crossref] [Google Scholar]